A Patient-Derived Screen Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Immunotherapy Partners
- DOI
- 10.1158/2326-6066.cir-25-0506
- Published
- 2026-08-27
- Container
- Cancer Immunology Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/2326-6066.cir-25-0506,
title = {A Patient-Derived Screen Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Immunotherapy Partners},
author = {Mona Khalaj and Andrew T. Burden and Madison L. Gutierrez and Sophia C. Hoonsbeen and Parisa Nejad and Tal Raveh and Jacob S. Young and Faranak Fattahi and Irving L. Weissman},
year = {2026},
journal = {Cancer Immunology Research},
doi = {10.1158/2326-6066.cir-25-0506},
url = {https://doi.org/10.1158/2326-6066.cir-25-0506}
}RIS
TY - JOUR TI - A Patient-Derived Screen Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Immunotherapy Partners AU - Mona Khalaj AU - Andrew T. Burden AU - Madison L. Gutierrez AU - Sophia C. Hoonsbeen AU - Parisa Nejad AU - Tal Raveh AU - Jacob S. Young AU - Faranak Fattahi AU - Irving L. Weissman PY - 2026 JO - Cancer Immunology Research DO - 10.1158/2326-6066.cir-25-0506 UR - https://doi.org/10.1158/2326-6066.cir-25-0506 ER -
APA
Khalaj, M., Burden, A. T., Gutierrez, M. L., Hoonsbeen, S. C., Nejad, P., Raveh, T., Young, J. S., Fattahi, F., & Weissman, I. L. (2026). A Patient-Derived Screen Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Immunotherapy Partners. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-25-0506
Source records
- crossref · retrieved 2026-09-26T15:22:11.455Z